HIGH THROUGHPUT DIAGNOSTIC LABORATORY

Seeking capital for acquisition.
40% rollover equity. Management staying on post-close. QoE available end of July. COVID revenue increase. Post covid revenue stabilized.

industry
[redacted]
location
[redacted]
revenue
[redacted]
ebitda
[redacted]


share: